Skip to main content
Premium Trial:

Request an Annual Quote

UK s HGMPRC and Genetix in 2.5 Million Deal to Build Speedy Protein Interaction Mapping Technology

NEW YORK, July 23—The Human Genome Mapping Project Resource Centre in Cambridge, UK, and the British robotics company Genetix have formed a three-year collaboration to develop equipment for speeding up protein identification and generating protein interaction maps. The technology is being funded through the UK’s LINK Programme in Applied Genomics, with £2.5 million to come jointly from the UK’s Department of Trade and Industry, Genetix, and the Medical Research Council, which houses the HGMPRC. 

The project will initially use yeast as a medium, later switching to mammalian cells to validate protein interactions in humans. It aims ultimately to enable the measurement of interactions between the protein products of all human genes, and to generate some one billion data points. The collaborators said that they expect the new system to increase the throughput of protein interaction studies by 1000 times. 

The LINK Programme in Applied  Genomics was established two years ago with  £15 million funding from the DTI, the Biotechnology and Biological Sciences Research Council, and MRC, to be matched by equal funding from industry. 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.